Dr Milan Dragovic
The Academic Details listed below present information collected by the University up to the end of 2013 and thus may not represent the full academic record.
Phone: 9347 6442
McCarthy, N.S., Melton, P.E., Ward, S.V., Allan, S.M., Dragovic, M., Clark, M., Morar, B., Rubio, J.P., Badcock, J.C., Morgan, V.A., Moses, E.K., Jablensky, A.V. 2017, 'Exome array analysis suggests an increased variant burden in families with schizophrenia', SCHIZOPHRENIA RESEARCH, December 2016, pp. 1-8. Detail
Laugharne, J., Waterreus, A.J., Castle, D.J., Dragovic, M. 2016, 'Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs', AUSTRALASIAN PSYCHIATRY, 24, 1, pp. 62-66. Detail
Bruce, D.G., Davis, W.A., Dragovic, M., Davis, T.M.E., Starkstein, S.E. 2016, 'Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II', Depression and Anxiety, 33, 10, pp. 960-966. Detail
Dragovic, M., Fajgelj, S., John, A.P. 2016, 'Do the generalised cognitive deficits observed in schizophrenia indicate a rapidly-ageing brain?', European Journal of Psychiatry, 30, 2, pp. 141-148. Detail
John, A.P., Dragovic, M. 2015, 'Antipsychotic polypharmacy is not associated with reduced dose of individual antipsychotics in schizophrenia', Journal of Clinical Psychopharmacology, 35, 2, pp. 193-195. Detail
Dr Johanna Badcock, Professor Assen Jablensky, Dr Milan Dragovic 2002, 'High functioning people with schizophrenia: Neurocognitive and clinical profile', WA Foundation for Research into Schizophrenic Disorders.
2010 PhD. Dr Mazhari. Supervised by: Prof Jablensky, Dr Waters, Dr Price, Dr Dragovic